Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00206206
Status:
TERMINATED
Last Update Posted:
2006-02-07
First Post:
2005-09-13
Brief Title:
Evaluation of an ICU Hyperglycemia Protocol Using Insulin Aspart
Sponsor:
Atlantic Health System
Organization:
Atlantic Health System
Study Overview
Official Title:
Evaluation of an ICU Hyperglycemia Protocol Using Insulin Aspart
Status:
TERMINATED
Status Verified Date:
2005-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In response to the evidence supporting tight glucose control 70 - 110 in the critical care setting the MMH ICU developed a protocol utilizing regular intravenous insulin This protocol was initiated in 2002 Monitoring of the data collected revealed effective glycemic control when this protocol was used However limited utilization has led to overall ineffective glycemic control in this ICU The poor utilization is largely due to a general reluctance of physicians to start their patients on an intravenous insulin infusion As contributing to this poor compliance is the open nature of the ICU The MMH ICU is an open ICU meaning that many physicians across multiple subspecialties admit to this unit Approaches to controlling hyperglycemia vary greatly depending largely upon the treating physician In an attempt to improve overall glycemic control in this open ICU the Subcutaneaous Insulin Aspart Hyperglycemia Protocol SIAP was developed which incorporates a subcutaneous insulin aspart regimen that triggers the use of a regular insulin infusion protocol when the SIAP is not adequately controlling the patients blood glucose
This study aims to evaluate 1 the effect the SIAP on overall glycemic control in the ICU 2 the effectiveness that the SIAP has on controlling blood glucose as compared with past practices using regular insulin and 3 the effect the SIAP has on patient complications and outcomes in the MMH ICU
This study aims to evaluate 1 the effect the SIAP on overall glycemic control in the ICU 2 the effectiveness that the SIAP has on controlling blood glucose as compared with past practices using regular insulin and 3 the effect the SIAP has on patient complications and outcomes in the MMH ICU
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None